In early January 2022 I initiated a Danaher (DHR) position and shared the following in my January 6 post: Based on DHR's track record and the extent to which the Life Sciences and Diagnostics segments have grown, I would not be surprised to learn of another spin-off in the future. Fast forward to September [...]
I last reviewed Intuitive Surgical (ISRG) in my July 23, 2022 post at which time it had just released Q2 2022 results. In that post, I disclosed the purchase of additional shares on July 22 at ~$210.24. Following that purchase, ISRG got caught up in the broad market sell-off. This gave investors a wonderful opportunity [...]
Lockheed Martin's irrational share price surge (~$35 increase on October 18 from the prior day's ~$397 closing share price) should make investors question whether this is due to irrational exuberance or due to a significant improvement in underlying fundamentals. I last reviewed Lockheed Martin (LMT) on July 19, 2022 at which time it had just [...]
As explained in my recent 3M (MMM) Is A Toxic Dividend King To Avoid guest post at Dividend Power, many investors gravitate to investments that offer attractive dividend metrics. Because of this, these same investors will automatically ignore Copart (CPRT) because it does not distribute a dividend. Unlike MMM, however, CPRT is rapidly growing (~$0.924B [...]
On February 14, 2022, I published a post entitled 3M: This Dividend King Is A Train Wreck. MMM's situation has deteriorated further as explained in my 3M (MMM) Is A Toxic Dividend King To Avoid guest post at Dividend Power. Once upon a time, MMM was viewed to be a wonderful long-term investment. How times [...]
Scotiabank (BNS) is an investment holding to which I pay very little attention. Quite frankly, if: I did not receive restricted share units as part of my employee compensation package an Employee Share Ownership Plan (ESOP) did not exist in which employees receive a 50% match up to a specific amount it likely would not [...]
In my May 29, 2022 post, I recommend investors pass on Cisco Systems (CSCO) despite its attractive valuation. I now disclose my exit since there are companies that can produce superior long-term investment returns. CSCO's credit risk is acceptable but its top-line growth is negligible despite having spent over $12B on acquisitions in the last [...]
In my Chevron Corporation (CVX) guest post at Dividend Power, I touch upon why I think expectations of the demise of the oil and gas industry are overblown. This post is the 3rd in a series of guest posts on integrated oil and gas producers. In my July 7 Imperial Oil (IMO) Is Gushing Free [...]
The Home Depot (HD) share price surge reduces its attractiveness. I suspect this surge is likely partially attributed to irrational exuberance! In my April 4, 2022 Home Depot (HD) post, I disclose the purchase of 200 shares @ ~$303.36 in a 'Side' account within the FFJ Portfolio. At that time, the most current financial information [...]
I first reviewed TELUS International (Cda) Inc. (TIXT) in my February 16, 2021 post at which time I disclosed a new 400-share position @ ~$39.48 in one of the 'Core' accounts in the FFJ Portfolio. Following the release of Q2 and YTD2021 results, I revisited TIXT in my August 1, 2021 post. Now that TIXT [...]